Mr. Gillis most recently led STI Technologies Limited (“STI”), a leading healthcare technology company which connects physicians, patients, pharmacy and pharma with a variety of intelligent reimbursement solutions that empower choice amongst healthcare professionals and patients, ultimately improving patient outcomes. As Chief Executive Officer, Mr. Gillis navigated STI through a period of hypergrowth which culminated in a sale to IQVIA (NYSE: IQV). Mr. Gillis has previously held senior positions with Stantec Inc. (TSX: STN) and Clarke Inc. (TSX: CKI) and throughout his career has completed over $345MM in strategic transactions.
“Tim Gillis is a dynamic leader and is experienced in growing a disruptive technology company in the pharma industry. He is an excellent fit as Nextleaf continues to develop and monetize its intellectual property portfolio focused on industrial-scale cannabis extraction, purification, and derivative formulations” said Paul Pedersen, Chief Executive Officer at Nextleaf. “Tim’s decades of operational and strategic experience in health care technology and the pharma industry will be an asset as we focus on building long term shareholder value.”
“Nextleaf is at an exciting stage with THC and CBD based edibles and concentrates set to become legal across Canadathis October. With its portfolio of issued and pending patents, the Company is well-positioned to capitalize on the global legalization movement,” said Tim Gillis. “I look forward to working with Nextleaf’s management team to leverage my experience in growing a technology company that specialized within the pharmaceutical industry. We are committed to fostering strong corporate governance by implementing best practices and positioning the Company as a technology leader in the cannabis industry.”
Concurrently with the addition of Mr. Gillis to the Board of Directors, Dr. Paul MacLeman has resigned as a director of Nextleaf to focus on his growing Australian business opportunities and commitments. Paul Pedersen said, “we would like to thank Mr. MacLeman for all his support and effort throughout an important stage of Nextleaf’s development.”
The Company has awarded a Director of the Company 150,000 options, pursuant to the Company’s Stock Option Plan, exercisable at a price of $0.50 per common share.
OILS is pleased to announce the Affirmation of Readiness and Video Evidence Package (the “Evidence Package”) has been submitted to Health Canada for Nextleaf’s built-out extraction and processing facility in Greater Vancouver, British Columbia. The Evidence Package submission is the final step required in order to demonstrate and confirm to Health Canada that a facility is fully built, operationally ready and in compliance with the Cannabis Act, prior to being issued a Standard Processing License. Health Canada has indicated a service standard within 60 days from submission of a completed Evidence Package.
Nextleaf Solutions Ltd. (CSE: OILS) is an extraction technology company that has developed a portfolio of issued and pending patents pertaining to the Company’s unique, industrial-scale process of producing purified cannabinoid distillate, a tasteless, odourless cannabis concentrate best suited for infusing premium value-added products. Upon cannabis concentrates becoming legal across Canada on October 17, 2019, Nextleaf plans to commercialize its intellectual property portfolio through B2B processing services to licensed cultivators and the supply of cannabis oils and concentrates to qualified Canadian and international partners.
The securities described herein, if any, have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any of OILS securities in the United States. This news release may contain “forward-looking information” as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of OILS, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of OILS and its subsidiaries as a going concern, general economic and market conditions, price of biomass, the accuracy of production resource estimates, and the performance of OILS future operations. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. Important factors that could cause actual results to differ materially from OILS’ expectations include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. For additional information with respect to risk factors applicable to OILS, reference should be made to OILS continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, OILS CSE Listing Statement. The forward-looking information contained in this release is made as of the date of this release. OILS does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The CSE has not reviewed, approved or disapproved the contents of this press release.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or